Cognitive decline profiles associated with lewy pathology in the context of Alzheimer’s disease neuropathologic change
Abstract Background Alzheimer’s disease neuropathologic change (ADNC) and Lewy pathology (LP) often coexist in cognitively impaired individuals. These pathologies’ relative distribution and severity may modify these individuals’ clinical presentation, cognitive profile, and prognosis. Therefore, we...
Saved in:
| Main Authors: | Jon B. Toledo, David P. Salmon, Melissa J. Armstrong, Douglas Galasko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-12-01
|
| Series: | Alzheimer’s Research & Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13195-024-01628-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lewy body dementia: exploring biomarkers and pathogenic interactions of amyloid β, tau, and α-synuclein
by: Jingfeng Liang, et al.
Published: (2025-08-01) -
Current strategies in the management of dementia with lewy bodies and future directions based on disease pathophysiology
by: Daniel Erskine, et al.
Published: (2025-07-01) -
Research on the perspectives of people affected by dementia with Lewy bodies: a scoping review
by: Paula Sinead Donnelly, et al.
Published: (2025-05-01) -
α-synuclein and tau: interactions, cross-seeding, and the redefinition of synucleinopathies as complex proteinopathies
by: Francisco J. Padilla-Godínez, et al.
Published: (2025-03-01) -
Anosognosia in dementia with Lewy bodies: a systematic review
by: Victor CALIL, et al.
Published: (2021-06-01)